Last reviewed · How we verify
NCT03404076: GISTm3
Unifying Advanced Treatment With Advanced Imaging
trial testing Dual Energy CT in Gastrointestinal Stromal Tumor (GIST) in 93 participants. Completed in 1 December 2020.
31 October 2020
Quick facts
| Lead sponsor | Heidelberg University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 93 |
| Start date | 1 December 2014 |
| Primary completion | 31 October 2020 |
| Estimated completion | 1 December 2020 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Dual Energy CT
Conditions studied
- Gastrointestinal Stromal Tumor (GIST) — all drugs for Gastrointestinal Stromal Tumor (GIST) →
Sponsor
Heidelberg University
Who can join
18 and older, any sex, with Gastrointestinal Stromal Tumor (GIST). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study investigates response assessment of gastrointestinal stromal tumors using Dual Energy CT (DECT) in patients undergoing targeted therapy with a TKI Inhibitor.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03404076
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dual Energy CT
Trials testing the same drug.
- NCT05758701 — CT TAVR Abdomen Study · Phase 4 · recruiting
- NCT05816239 — LUng voluMe reductIoN by DuAl ENergy CT Evaluation (LUMINANCE) Study · completed
Other recruiting trials for Gastrointestinal Stromal Tumor (GIST)
Currently open trials in the same condition.
- NCT07072143 — An International Study on Pediatric Patients With Rare Tumors. · recruiting
- NCT05489237 — First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors · Phase 1 · recruiting
- NCT04557969 — Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis · recruiting
Other Heidelberg University trials
Trials by the same sponsor.
- NCT07106294 — Hyperspectral Imaging for Prediction of Preeclampsia · recruiting
- NCT06651164 — Psychosomatic Risk Screening · NA · completed
- NCT07378345 — Optimization of Communication Between Surgery and Pathology · NA · completed
- NCT06018272 — Mentalization-based Treatment Versus Bona-fide Treatment for Patients With Borderline Personality Disorder in Germany · NA · recruiting
- NCT06852599 — Long-term Outcomes of Implants in Patients with Periodontitis · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03404076 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Heidelberg University
- Last refreshed: 7 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03404076.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing